Sun, Sep 21, 2014, 9:17 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Amicus Therapeutics, Inc. (FOLD) Message Board

  • whogo70 whogo70 Dec 19, 2012 9:54 PM Flag

    If you review the 3rd qtr CC management

    stated that any risk of failure was due to consistency with the biopsy results. I'm sure management was shocked to see the placebo effect since this should have been zero. The good thing is that the preliminary secondary endpoints for the 6 month data clearly shows migalastat works. This combined with the 12 month data we'll see in the 1st qtr will get the program back on track for FDA approval.

    I wouldn't be surprised to see positive Pompe data next week & a CC where management can explain the plans going forward. We'll probably be trading over $4 before the end of year.

    Bought more in AH.

6.61-0.09(-1.34%)Sep 19 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Genworth Financial, Inc.
NYSEFri, Sep 19, 2014 4:03 PM EDT
Hercules Offshore, Inc.
NasdaqGSFri, Sep 19, 2014 4:00 PM EDT